<DOC>
	<DOCNO>NCT02221284</DOCNO>
	<brief_summary>The purpose survey evaluate safety efficacy long-term use alogliptin tablet ( Nesina Tablets ) type 2 diabetic patient inadequate response hypoglycemic agent ( e.g. , insulin preparation rapid-acting insulin secretagogues ) * addition dietary/exercise therapy daily medical practice . * Patients receive hypoglycemic agent ( exclude α-glucosidase inhibitor , thiazolidines , sulfonylurea , biguanides ) exclude exist specify drug-use survey Nesina Tablets .</brief_summary>
	<brief_title>Alogliptin Tablets Specified Drug-use Survey `` Type 2 Diabetic Patients Receiving Combination Therapy With Hypoglycemic Agent ( e.g. , Insulin Preparations Rapid-acting Insulin Secretagogues ) ''</brief_title>
	<detailed_description>This survey design evaluate safety efficacy long-term use alogliptin tablet ( Nesina Tablets ) type 2 diabetic patient inadequate response hypoglycemic agent ( e.g. , insulin preparation rapid-acting insulin secretagogues ) * addition dietary/exercise therapy daily medical practice . For adult , 25 mg alogliptin usually administer orally daily .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Alogliptin</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<criteria>Type 2 diabetic patient meet follow criterion include survey : Patients inadequate response follow medications/therapies : • Use one hypoglycemic agent insulin preparation rapidacting insulin secretagogues , exclude type hypoglycemic agent ( e.g. , αglucosidase inhibitor , thiazolidines , sulfonylurea , biguanides ) * , addition dietary/exercise therapy * For use Nesina Tablets combination agent , specify druguse survey currently ongoing . Type 2 diabetic patient meet follow criterion exclude survey : Patients contraindication Nesina Tablets 1 . Those severe ketosis , state diabetic coma precoma , type 1 diabetes mellitus [ Quickly rectify hyperglycemia administration intravenous fluid insulin essential patient ; therefore , administration Nesina Tablets appropriate . ] 2 . Those severe infection , surgery , serious trauma [ Controlling blood glucose injection insulin desirable patient ; therefore , administration Nesina Tablets appropriate . ] 3 . Those history hypersensitivity ingredient Nesina Tablets</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>